Dec 23, 2021· Comment from Parenteral Drug Association· FDA-2021-D-1031-0008
The Parenteral Drug Association (PDA) is a non-profit international professional association of individual member scientists having an interest in the fields of pharmaceutical, biological, and device manufacturing and quality. Our comments in the attached letter on the draft guidance have been prepared by members of PDA's Regulatory Affairs and Quality Advisory Board on behalf of PDA's Board of Directors.